chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: has not had second shot, past 42 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (has not had second shot, past 42 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (has not had second shot, past 42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (has not had second shot, past 42 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was provided by the reporter.  No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizziness). At the time of the report, DIZZINESS (Dizziness) outcome was unknown.            No concomitant medications were reported. No treatment was reported.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Gave the first shot of Moderna Covid 19 Vaccine to a 14 years old patient; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave the first shot of Moderna Covid 19 Vaccine to a 14 years old patient) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave the first shot of Moderna Covid 19 Vaccine to a 14 years old patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave the first shot of Moderna Covid 19 Vaccine to a 14 years old patient) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not reported.  The treatment information was not provided.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Skin reaction, Urticaria
Clinical narrative: hives; skin type reactions; shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles), URTICARIA (hives) and SKIN REACTION (skin type reactions) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced HERPES ZOSTER (shingles). On an unknown date, the patient experienced URTICARIA (hives) and SKIN REACTION (skin type reactions). In May 2021, HERPES ZOSTER (shingles) had resolved. At the time of the report, URTICARIA (hives) and SKIN REACTION (skin type reactions) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant product information was not provided.  Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Additional event herpes zoster after first dose.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: missed her second dose and as of 26May2021 it has been 58 days since her first dose.; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed her second dose and as of 26May2021 it has been 58 days since her first dose.) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed her second dose and as of 26May2021 it has been 58 days since her first dose.). On 26-May-2021, PRODUCT DOSE OMISSION ISSUE (missed her second dose and as of 26May2021 it has been 58 days since her first dose.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was provided by the reporter.  No treatment information was provided.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Gave both first shot of Moderna Covid 19 Vaccine to 2 patients (ages: 17 and 14 years old); This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave both first shot of Moderna Covid 19 Vaccine to 2 patients (ages: 17 and 14 years old)) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave both first shot of Moderna Covid 19 Vaccine to 2 patients (ages: 17 and 14 years old)). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave both first shot of Moderna Covid 19 Vaccine to 2 patients (ages: 17 and 14 years old)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not reported.  The treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: The follow-up was received on 9-JUN-2021 and has no new information.
Sex: U
Vaccine: COVID19
Symptoms: Thrombosis
Clinical narrative: possible blood clot for the event of thrombosis; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (possible blood clot for the event of thrombosis) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (possible blood clot for the event of thrombosis). At the time of the report, THROMBOSIS (possible blood clot for the event of thrombosis) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  No concomitant medications were reported.  No Treatments were reported.  Company Comment: Very limited information regarding this event has been provided at this time. No further information is expected at this time.; Sender's Comments: Very limited information regarding this event has been provided at this time. No further information is expected at this time.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Entire arm is numb; Entire arm is tingling; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Entire arm is numb) and PARAESTHESIA (Entire arm is tingling) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Entire arm is numb) and PARAESTHESIA (Entire arm is tingling). At the time of the report, HYPOAESTHESIA (Entire arm is numb) and PARAESTHESIA (Entire arm is tingling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment information was unknown.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose of Vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). On 25-May-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported  No treatment drugs were reported
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue, Vertigo
Clinical narrative: Vertigo; haven't received the second one yet; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) and PRODUCT DOSE OMISSION ISSUE (haven't received the second one yet) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Vertigo) and PRODUCT DOSE OMISSION ISSUE (haven't received the second one yet). The patient was treated with MECLIZINE HYDROCHLORIDE at an unspecified dose and frequency. At the time of the report, VERTIGO (Vertigo) had not resolved and PRODUCT DOSE OMISSION ISSUE (haven't received the second one yet) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Significant Follow-up. Outcome for the event vertigo and contact information updated.
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: He is miserable today; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (He is miserable today) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, the patient experienced FEELING ABNORMAL (He is miserable today). At the time of the report, FEELING ABNORMAL (He is miserable today) outcome was unknown.            No concomitant medications were reported.  No treatment was reported.
Sex: F
Vaccine: COVID19
Symptoms: Interleukin level increased
Clinical narrative: My wife had higher IL6 response with her 2nd dose of the Moderna Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INTERLEUKIN LEVEL INCREASED (My wife had higher IL6 response with her 2nd dose of the Moderna Covid-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient has no medical history reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced INTERLEUKIN LEVEL INCREASED (My wife had higher IL6 response with her 2nd dose of the Moderna Covid-19 vaccine). At the time of the report, INTERLEUKIN LEVEL INCREASED (My wife had higher IL6 response with her 2nd dose of the Moderna Covid-19 vaccine) outcome was unknown.            Concomitant medication was not reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: NNI
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Pain, Vaccination site erythema, Vaccination site mass, Vaccination site pain
Clinical narrative: huge knot/tiny knot; burning; shooting pain; red; pain; itching; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (huge knot/tiny knot), BURNING SENSATION (burning), PAIN (shooting pain), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (huge knot/tiny knot), BURNING SENSATION (burning), PAIN (shooting pain), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PAIN (pain) and VACCINATION SITE PRURITUS (itching). At the time of the report, VACCINATION SITE MASS (huge knot/tiny knot), BURNING SENSATION (burning), PAIN (shooting pain), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PAIN (pain) and VACCINATION SITE PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product was not provided. treatment medication was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: huge knot/tiny knot; burning; shooting pain; red; pain; itching; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (huge knot/tiny knot), BURNING SENSATION (burning), PAIN (shooting pain), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE MASS (huge knot/tiny knot), BURNING SENSATION (burning), PAIN (shooting pain), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PAIN (pain) and VACCINATION SITE PRURITUS (itching). At the time of the report, VACCINATION SITE MASS (huge knot/tiny knot), BURNING SENSATION (burning), PAIN (shooting pain), VACCINATION SITE ERYTHEMA (red), VACCINATION SITE PAIN (pain) and VACCINATION SITE PRURITUS (itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product was not provided. treatment medication was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was provided by the reporter.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Feeling abnormal, Musculoskeletal stiffness, Pyrexia, Vaccination site pain
Clinical narrative: Arm hurts badly; whole body is stiff; 99.6 temperature; Feel very crappy; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Arm hurts badly), MUSCULOSKELETAL STIFFNESS (whole body is stiff), PYREXIA (99.6 temperature) and FEELING ABNORMAL (Feel very crappy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Arm hurts badly), MUSCULOSKELETAL STIFFNESS (whole body is stiff), PYREXIA (99.6 temperature) and FEELING ABNORMAL (Feel very crappy). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Arm hurts badly), MUSCULOSKELETAL STIFFNESS (whole body is stiff), PYREXIA (99.6 temperature) and FEELING ABNORMAL (Feel very crappy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 99.6 (High) Abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications include medications for acid reflux.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose of Vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). On 25-May-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information was provided by the reporter.  No treatment information was provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in the right arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the right arm) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Latex allergy.    On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, the patient experienced PAIN IN EXTREMITY (Pain in the right arm). At the time of the report, PAIN IN EXTREMITY (Pain in the right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications included natural drops for sleeping.  The treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: The follow-up was received on 9-JUN-2021 and has no new information.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypersensitivity, Inflammation, Peripheral swelling, Pruritus
Clinical narrative: Allergic reaction; Swollen arm; Really red; Itchy/ itching a lot; Inflamed; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (Really red), PRURITUS (Itchy/ itching a lot), INFLAMMATION (Inflamed) and HYPERSENSITIVITY (Allergic reaction) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     The patient's past medical history included Hospitalization (This  2nd dose was delayed because she was in the hospital.). Concomitant products included ROSUVASTATIN for Cholesterol, METFORMIN for Diabetes, HYDROCHLOROTHIAZIDE for Diuretic therapy, THIAMAZOLE (METHIMAZOLE) for Thyroid therapy, PROPRANOLOL, ALPRAZOLAM, TEMAZEPAM and DOXAZOSIN for an unknown indication.    On 24-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-May-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (Really red), PRURITUS (Itchy/ itching a lot) and INFLAMMATION (Inflamed). On an unknown date, the patient experienced HYPERSENSITIVITY (Allergic reaction). At the time of the report, PERIPHERAL SWELLING (Swollen arm), ERYTHEMA (Really red), PRURITUS (Itchy/ itching a lot), INFLAMMATION (Inflamed) and HYPERSENSITIVITY (Allergic reaction) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment provided was Benadryl.   Production indication of medications Propranolol is beta blocker, alprazolam is benzodiazepine , temazepam is benzodiazepine and doxazosin is alpha blocker.  Patient mentioned that the vaccination provider placed a round, Band-Aid like thing on arm before giving the injection that they did not do for the first injection.patient  described it as a white circle with a thin material. The first dose was also given in the left arm on 08Apr2021 and the lot number is 037A21B   This case was linked to MOD-2021-072929 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: incomplete dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (incomplete dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced INCORRECT DOSE ADMINISTERED (incomplete dose). At the time of the report, INCORRECT DOSE ADMINISTERED (incomplete dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided. Treatment information was not provided.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Swelling face
Clinical narrative: Face is swollen/Face is lingering on; Hands are swollen; This spontaneous case was reported by a patient and describes the occurrence of SWELLING FACE (Face is swollen/Face is lingering on) and PERIPHERAL SWELLING (Hands are swollen) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes mellitus, Asthma and Blood pressure high.    On 12-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced SWELLING FACE (Face is swollen/Face is lingering on) and PERIPHERAL SWELLING (Hands are swollen). At the time of the report, SWELLING FACE (Face is swollen/Face is lingering on) and PERIPHERAL SWELLING (Hands are swollen) outcome was unknown.            Concomitant medications not provided. Treatment information was not provided. Patient mentioned that he got first vaccine, he does not remember the date  but he stated it was the Moderna COVID-19 vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, SARS-CoV-2 antibody test
Clinical narrative: Got the vaccine within three weeks of infusion/ can we repeat thevaccination again as she is now 5 months from her last rituximab infusion; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Got the vaccine within three weeks of infusion/ can we repeat thevaccination again as she is now 5 months from her last rituximab infusion) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Autoimmune disorder NOS. Concomitant products included RITUXIMAB for Autoimmune disorder.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Got the vaccine within three weeks of infusion/ can we repeat thevaccination again as she is now 5 months from her last rituximab infusion). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Got the vaccine within three weeks of infusion/ can we repeat thevaccination again as she is now 5 months from her last rituximab infusion) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative (Negative) COVID19 spike protein Ab which are negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: i cant step away from a toliet; have to sleep there;  i just put what into my body that keeps me on my toliet for 30 hrs?; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (i cant step away from a toliet; have to sleep there;  i just put what into my body that keeps me on my toliet for 30 hrs?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced DIARRHOEA (i cant step away from a toliet; have to sleep there;  i just put what into my body that keeps me on my toliet for 30 hrs?). At the time of the report, DIARRHOEA (i cant step away from a toliet; have to sleep there;  i just put what into my body that keeps me on my toliet for 30 hrs?) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Movement disorder, Pain in extremity
Clinical narrative: after 2nd vaccine he could barely raise his left arm above his head; arm pain left; usual chills; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 26-May-2021. The most recent information was received on 27-Jul-2021 and was forwarded to Moderna on 27-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (after 2nd vaccine he could barely raise his left arm above his head), PAIN IN EXTREMITY (arm pain left) and CHILLS (usual chills) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 7006320004 and 7006320001) for COVID-19 vaccination.     The patient's past medical history included Cancer. Previously administered products included for an unreported indication: INFLUENZA. Concurrent medical conditions included Coronary disease.   On 01-Sep-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Oct-2020, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Oct-2020, the patient experienced MOVEMENT DISORDER (after 2nd vaccine he could barely raise his left arm above his head), PAIN IN EXTREMITY (arm pain left) and CHILLS (usual chills). On 14-Oct-2020, CHILLS (usual chills) had resolved. On 17-Oct-2020, MOVEMENT DISORDER (after 2nd vaccine he could barely raise his left arm above his head) and PAIN IN EXTREMITY (arm pain left) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered PAIN IN EXTREMITY (arm pain left) and CHILLS (usual chills) to be possibly related. No further causality assessment was provided for MOVEMENT DISORDER (after 2nd vaccine he could barely raise his left arm above his head).    No treatment information or concomitant medications were provided by reporter. Action taken with the drug in response to the events was not provided by the Reporter.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow-up received included no new information. On 27-Jul-2021: Significant follow up received - Patient demographics, medical history, vaccination facility details updated, new event pain in arm added, stop date for event chills were updated.
Sex: U
Vaccine: COVID19
Symptoms: Feeling hot, Paraesthesia, Thermal burn
Clinical narrative: After less than a day i feel hot; tingly; sun burn not registering a fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (After less than a day i feel hot), PARAESTHESIA (tingly) and THERMAL BURN (sun burn not registering a fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (After less than a day i feel hot), PARAESTHESIA (tingly) and THERMAL BURN (sun burn not registering a fever). At the time of the report, FEELING HOT (After less than a day i feel hot), PARAESTHESIA (tingly) and THERMAL BURN (sun burn not registering a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were reported. No treatment was reported.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pruritus, Hypersensitivity, Pruritus, Rash, Throat irritation
Clinical narrative: Itchy throat; Itchy tongue; Ears itch; Eyes itch; allergic reaction; Rash; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Itchy throat), TONGUE PRURITUS (Itchy tongue), PRURITUS (Ears itch), EYE PRURITUS (Eyes itch) and HYPERSENSITIVITY (allergic reaction) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seafood allergy and Allergy to nuts.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced THROAT IRRITATION (Itchy throat), TONGUE PRURITUS (Itchy tongue), PRURITUS (Ears itch), EYE PRURITUS (Eyes itch), HYPERSENSITIVITY (allergic reaction) and RASH (Rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. At the time of the report, THROAT IRRITATION (Itchy throat), TONGUE PRURITUS (Itchy tongue), PRURITUS (Ears itch), EYE PRURITUS (Eyes itch), HYPERSENSITIVITY (allergic reaction) and RASH (Rash) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Tongue pruritus
Clinical narrative: Itchy throat; Itchy tongue; Ears itch; Eyes itch; allergic reaction; Rash; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Itchy throat), TONGUE PRURITUS (Itchy tongue), PRURITUS (Ears itch), EYE PRURITUS (Eyes itch) and HYPERSENSITIVITY (allergic reaction) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seafood allergy and Allergy to nuts.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced THROAT IRRITATION (Itchy throat), TONGUE PRURITUS (Itchy tongue), PRURITUS (Ears itch), EYE PRURITUS (Eyes itch), HYPERSENSITIVITY (allergic reaction) and RASH (Rash). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. At the time of the report, THROAT IRRITATION (Itchy throat), TONGUE PRURITUS (Itchy tongue), PRURITUS (Ears itch), EYE PRURITUS (Eyes itch), HYPERSENSITIVITY (allergic reaction) and RASH (Rash) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: fever; headache; body ache; major fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), HEADACHE (headache), MYALGIA (body ache) and FATIGUE (major fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 24-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-May-2021, the patient experienced PYREXIA (fever) and HEADACHE (headache). 25-May-2021, the patient experienced MYALGIA (body ache) and FATIGUE (major fatigue). At the time of the report, PYREXIA (fever), HEADACHE (headache), MYALGIA (body ache) and FATIGUE (major fatigue) outcome was unknown.            No concomitant and treatment medications were reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Migraine, Pain in extremity, Vomiting
Clinical narrative: throwing up for a few days; arm soreness; migraine right when I finished waiting; felt a gland in my throat swelling; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (arm soreness), MIGRAINE (migraine right when I finished waiting), LYMPHADENOPATHY (felt a gland in my throat swelling) and VOMITING (throwing up for a few days) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 01-Jul-2020 and Allergic reaction NOS. Concomitant products included SUMATRIPTAN SUCCINATE (IMITREX DF), ATENOLOL, VALPROATE SEMISODIUM (DIVALPROEX) and ACETAZOLAMIDE for Migraine, TRAMADOL, LEVOTHYROXINE, FUROSEMIDE (LASIX [FUROSEMIDE]) and VITAMIN D [VITAMIN D NOS] for an unknown indication.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), MIGRAINE (migraine right when I finished waiting) and LYMPHADENOPATHY (felt a gland in my throat swelling). On 30-Apr-2021, the patient experienced VOMITING (throwing up for a few days). At the time of the report, PAIN IN EXTREMITY (arm soreness), MIGRAINE (migraine right when I finished waiting), LYMPHADENOPATHY (felt a gland in my throat swelling) and VOMITING (throwing up for a few days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-177302 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Follow-up information  received on 30-Jun-2021 contains No New Information.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Molluscum contagiosum
Clinical narrative: Mollusccum contagiosum; This spontaneous case was reported by a consumer and describes the occurrence of MOLLUSCUM CONTAGIOSUM (Mollusccum contagiosum) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced MOLLUSCUM CONTAGIOSUM (Mollusccum contagiosum). The patient was treated with EZETIMIBE ongoing since an unknown date at a dose of 1 dosage form; PANTOPRAZOLE ongoing since an unknown date at a dose of 1 dosage form; IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form and COLCHICINE ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, MOLLUSCUM CONTAGIOSUM (Mollusccum contagiosum) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-177290 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in my arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (pain in my arm). At the time of the report, PAIN IN EXTREMITY (pain in my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment drugs were reported
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Paraesthesia, Vaccination site nerve damage
Clinical narrative: Patient think a nerve was probably hit when the vaccine was given; Patient right arm where it got injected was half asleep and sparkle like tingles; Patient was light headed; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NERVE DAMAGE (Patient think a nerve was probably hit when the vaccine was given), PARAESTHESIA (Patient right arm where it got injected was half asleep and sparkle like tingles) and DIZZINESS (Patient was light headed) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE NERVE DAMAGE (Patient think a nerve was probably hit when the vaccine was given), PARAESTHESIA (Patient right arm where it got injected was half asleep and sparkle like tingles) and DIZZINESS (Patient was light headed). At the time of the report, VACCINATION SITE NERVE DAMAGE (Patient think a nerve was probably hit when the vaccine was given) and DIZZINESS (Patient was light headed) outcome was unknown and PARAESTHESIA (Patient right arm where it got injected was half asleep and sparkle like tingles) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.     Reporter did not allow further contact
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Received Expired Dose of Vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose of Vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old who received Moderna; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old who received Moderna) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old who received Moderna). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old who received Moderna) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drug was not reported. Treatment medication was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Follow-up information contains Vaccine facility  information, adverse event On 23-Jul-2021: Follow up information contains no Adverse reaction have been  reported by patient.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Gait disturbance, Muscle spasms, Nausea
Clinical narrative: Hard for me to stand and walk; My legs hurt from the cramps; Feel a spasm on the chin of my knee; I feel nauseous; Had diarrhea every 15 minutes; This spontaneous case was reported by an other health care professional and describes the occurrence of DIARRHOEA (Had diarrhea every 15 minutes), GAIT DISTURBANCE (Hard for me to stand and walk), MUSCLE SPASMS (My legs hurt from the cramps), ARTHRALGIA (Feel a spasm on the chin of my knee) and NAUSEA (I feel nauseous) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in July 2020. Concurrent medical conditions included Migraine and Allergic reaction NOS (Severe allergic reactions). Concomitant products included SUMATRIPTAN (IMITREX [SUMATRIPTAN]), ATENOLOL, VALPROATE SEMISODIUM (DIVALPROEX), ACETAZOLAMIDE and FUROSEMIDE (LASIX [FUROSEMIDE]) for Migraine, TRAMADOL, COLECALCIFEROL (D) and LEVOTHYROXINE for an unknown indication.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-May-2021, the patient experienced DIARRHOEA (Had diarrhea every 15 minutes). On 26-May-2021, the patient experienced GAIT DISTURBANCE (Hard for me to stand and walk), MUSCLE SPASMS (My legs hurt from the cramps), ARTHRALGIA (Feel a spasm on the chin of my knee) and NAUSEA (I feel nauseous). At the time of the report, DIARRHOEA (Had diarrhea every 15 minutes), GAIT DISTURBANCE (Hard for me to stand and walk), MUSCLE SPASMS (My legs hurt from the cramps), ARTHRALGIA (Feel a spasm on the chin of my knee) and NAUSEA (I feel nauseous) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were unknown.   This case was linked to MOD-2021-177203 (Patient Link).